14-day Premium Trial Subscription Try For FreeTry Free
GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreemen
Surmodics (SRDX) registered revenue growth in each of its core units viz. In Vitro Diagnostics and Medical Device in Q3.
Cambridge Investment Research Advisors Inc. lowered its holdings in Opko Health Inc. (NASDAQ:OPK) by 7.4% during the second quarter, according to the company in its most recent Form 13F filing with th
Is (OPK) Outperforming Other Medical Stocks This Year?
Nevro's (NVRO) domestic and international revenues declined on a year-over-year basis in Q2.
GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress resu
MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, Aug

Unusual Options Activity Insight: OPKO Health

05:40pm, Monday, 03'rd Aug 2020
On Monday, shares of OPKO Health (NASDAQ: OPK) saw unusual options activity. After the option activity alert, the stock price moved up to $5.25. * Sentiment: BEARISH * Option Type: SWEEP * Trade Ty
Does OPKO Health (OPK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Unusual Options Activity Insight: OPKO Health

12:00am, Monday, 03'rd Aug 2020
On Monday, shares of OPKO Health (NASDAQ: OPK) saw unusual options activity. After the option activity alert, the stock price moved up to $5.25. Sentiment: BEARISH Option Type:...
Creative Planning boosted its position in shares of Opko Health Inc. (NASDAQ:OPK) by 381.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund ow
So far Saturday, August 1, NASDAQ is down -1.01% and the S&P is up 0.5%. Let’s take a look at
Opko Health (NASDAQ: OPK) -- considered a coronavirus stock thanks to its BioReference Laboratories, which has diagnostics products that test for the globe's top health threat at the moment -- closed
NextGen (NXGN) benefited from its Recurring segment in Q1.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE